Duke Univ Medical Center Oncology

Durham, North Carolina 27710

We've found

1 trials

at this facility

Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Durham, NC

Use our guide to learn which trials are right for you!